Tuberculoses lors de traitements par l’infliximab
- 1 March 2005
- journal article
- Published by Elsevier in La Presse Médicale
- Vol. 34 (5) , 353-357
- https://doi.org/10.1016/s0755-4982(05)83925-9
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapyArthritis & Rheumatism, 2004
- Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active‐surveillance reportArthritis & Rheumatism, 2003
- Tuberculosis following therapy with infliximab may be refractory to antibiotic therapyRheumatology, 2003
- Exacerbation of tuberculosis enteritis after treatment with infliximab.The American Journal of Medicine, 2002
- Anticorps anti-TNFα (infliximab) et tuberculose :à propos de trois casLa Revue de Médecine Interne, 2002
- Recommendations about the prevention and management of tuberculosis in patients taking infliximabJoint Bone Spine, 2002
- Tuberculosis and Treatment with InfliximabNew England Journal of Medicine, 2002
- Exacerbation of mycobacterium tuberculosis enteritis masquerading as crohn’s disease after treatment with a tumor necrosis factor-α inhibitorThe American Journal of Medicine, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000